Latest / Stock Movers / Nike Slumps, Intel Jumps, Eli Lilly Climbs
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, Podcasts, radio News.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 3: I'm Jim Stenoveek with Carol Masser. We are joined by
- 0:19Speaker 3: Bloomberg Television Markets correspondent Nora Melnda for some stocks on
- 0:24Speaker 3: the move? What do you got, Noura?
- 0:27Speaker 4: So we can't stop talking about Nike. That's what I've
- 0:29Speaker 4: got in mind to start things off. Ticker ink e
- 0:33Speaker 4: a brutal day for the company, down about sixteen percent
- 0:36Speaker 4: if you look at the size and scope, the lowest
- 0:38Speaker 4: level since October of twenty fourteen. So no great investors
- 0:43Speaker 4: not really liking what came out of earning, so they
- 0:45Speaker 4: said that they expect revenue to decline this quarter and
- 0:48Speaker 4: through the rest of this year. But what we do
- 0:50Speaker 4: know is we've been getting reporting that the CEO, Elliott Hill,
- 0:53Speaker 4: was telling staff that he wants to shift from fixing
- 0:56Speaker 4: the business to actually driving growth. So we do understand
- 0:59Speaker 4: that he did breast some frustrations there. But I mean,
- 1:02Speaker 4: I've also just been looking at the performance of the company,
- 1:04Speaker 4: and we know that this has really been a company
- 1:06Speaker 4: that's been really struggling to chart a turnaround story. The
- 1:09Speaker 4: stock is not about thirty percent so far in twenty
- 1:12Speaker 4: twenty six. But interestingly, Wall Street I was looking about
- 1:15Speaker 4: fifty seven percent of the analysts still say to buy
- 1:18Speaker 4: the stock. But you know, I think in terms of
- 1:20Speaker 4: Wall Street in their perception today, at least they weren't
- 1:23Speaker 4: too pleased.
- 1:23Speaker 5: Wasn't it when the numbers crossed?
- 1:24Speaker 1: They we didn't get the outlook right away right all
- 1:27Speaker 1: this country, we were all just kind of waiting for
- 1:29Speaker 1: a yeah, and then we get it. Weakness and greater
- 1:31Speaker 1: China re fallowing Converse sales or among management's biggest challenges.
- 1:36Speaker 1: China is a story we've been talking about for a
- 1:38Speaker 1: while with Nike.
- 1:39Speaker 5: See China.
- 1:39Speaker 4: I did know I thought the Converse were timeless.
- 1:43Speaker 5: No, I don't know. I don't really wear Converse. The
- 1:46Speaker 5: daughter chick Taylor's right, Yeah, I guess so, I don't know.
- 1:50Speaker 5: You know what's amazing?
- 1:50Speaker 3: They're padding, aren't they what?
- 1:55Speaker 4: I'm curious?
- 1:56Speaker 5: Okay?
- 1:57Speaker 3: Authentic? Well, we reported yesterday Lillie Meyer and Eliza Ronaldshannon
- 2:01Speaker 3: that a potential suitor for Converse could be an Authentic
- 2:04Speaker 3: Brands group. They've expressed interest in buying Converse if it's
- 2:07Speaker 3: put up for sale. According to people familiar with the masters,
- 2:11Speaker 3: can I just.
- 2:11Speaker 1: Tell you often when I am on a subway or
- 2:14Speaker 1: even this morning, I was walking through the platform, the
- 2:17Speaker 1: subway platform, and I wanted to take a video as
- 2:19Speaker 1: I walked along, because everybody has sneakers on. Yeah, everybody,
- 2:23Speaker 1: and they're all different kinds of brands. It is such
- 2:26Speaker 1: a crowded competitive field. And I know nice all birds
- 2:29Speaker 1: right right, exactly, all Birds. I remember when they came
- 2:32Speaker 1: out bottom bottom bottom, but I haven't bought them for
- 2:36Speaker 1: years a minute.
- 2:37Speaker 3: Right now, they're winding down after selling assets for thirty
- 2:39Speaker 3: nine million dollars.
- 2:40Speaker 1: The thing is Nike is iconic, and I'm not quite sure.
- 2:43Speaker 1: Is it a bigger nut and harder to move?
- 2:46Speaker 5: I don't know, I don't know.
- 2:48Speaker 3: I just want to add one more thing. The interest
- 2:50Speaker 3: is long standing. Nike so far hasn't engaged in discussions
- 2:53Speaker 3: with the owner of Reeboking Champion, nor has Authentic made
- 2:56Speaker 3: any official overture. According to the people who asked not
- 2:58Speaker 3: to be identified because they weren't authorized to speak publicly about.
- 3:01Speaker 1: The situation, I'm going to go back to the CFO
- 3:03Speaker 1: saying they're going to be imagining costs carefully, so that's
- 3:05Speaker 1: going to put pressure on everybody as they as they
- 3:07Speaker 1: try to make things turn around.
- 3:08Speaker 5: Sorry, we like this story too, it's interesting. Thank you,
- 3:12Speaker 5: multiple chapters to unfold.
- 3:13Speaker 4: Well, this is a going to name that ended in
- 3:15Speaker 4: the green today and we can't share some of intel
- 3:17Speaker 4: I INTC closing hired by about eight percent today. This
- 3:20Speaker 4: is after the company agreed to pay about fourteen billion
- 3:23Speaker 4: dollars to pay back half of a plant in Ireland
- 3:26Speaker 4: that it had previously sold to Apollo Global so Da Davidson,
- 3:30Speaker 4: the analyst over there, did say that they think that
- 3:32Speaker 4: this move bodes well for the company's turnaround story. The
- 3:35Speaker 4: deal will apparently be funded with cash on hand and
- 3:39Speaker 4: roughly about six and a half billion dollars in new debt.
- 3:42Speaker 4: So clearly Wall Street was happy with this, and you know,
- 3:46Speaker 4: stock ending higher on the day. Sixty nine percent of
- 3:49Speaker 4: analysts on Wall Street do say though, to hold the stock.
- 3:53Speaker 4: We know that this company is up about thirty percent
- 3:55Speaker 4: so far in twenty twenty six.
- 3:57Speaker 1: Got to believe they're not going to do this unless
- 3:58Speaker 1: they're upbeate about the outlook. Make that spend let's go
- 4:01Speaker 1: on over to a couple of drugstocks.
- 4:03Speaker 4: Yeah, I mean, whenever you're looking for news, I feel
- 4:05Speaker 4: that you know your biotechs, your drug companies, healthcare, they're
- 4:08Speaker 4: always moving. I'm looking at shares of e Take your
- 4:11Speaker 4: l Y as well as Novo Nordis ADRs take your Vo.
- 4:15Speaker 4: So we did see Eliley closing higher by about three percent.
- 4:19Speaker 4: We do know that the FDA did approve the drug
- 4:21Speaker 4: maker's obesity pill Fundio under the agency's National Priority Voucher
- 4:26Speaker 4: Pilot program. We know what's kind of been a back
- 4:29Speaker 4: and forth with these two companies. They're obviously always duking
- 4:32Speaker 4: it out, I mean, but both of them really struggled
- 4:34Speaker 4: this year. So it's really about which company is able
- 4:36Speaker 4: to bring new things online that their investors can really
- 4:39Speaker 4: sink their teeth into. And especially when we think about
- 4:42Speaker 4: the fact that the OBCD space has been a really
- 4:44Speaker 4: you know, buoyant, what popular industry as of late, this
- 4:50Speaker 4: is where they really want to lean into. But both
- 4:51Speaker 4: stocks are down so far this year. Ellllly shares down
- 4:54Speaker 4: by about eleven percent and Novo Nordius ADR is down
- 4:57Speaker 4: by twenty eight percent in twenty twenty.
- 4:59Speaker 5: Six, big all right, good stuff.
- 5:01Speaker 1: Check out our Stockmovers podcast, five minute episodes of the
- 5:04Speaker 1: big winners and losers in the stock market. Find it
- 5:06Speaker 1: on Apple, Spotify or anywhere.
- 5:08Speaker 2: Getsch podcast the Stockmover's Report from Bloomberg Radio. Check back
- 5:14Speaker 2: with us throughout the day for the latest roundup of
- 5:16Speaker 2: companies making news on Wall Street and for the latest
- 5:19Speaker 2: market moving headlines. Listen to Bloomberg Radio Live, catch us
- 5:24Speaker 2: on YouTube, Bloomberg dot com, and on Applecarplay and Android
- 5:27Speaker 2: Auto with the Bloomberg Business app.